Gilead Sciences (GILD) Current Deferred Tax Assets (2009 - 2016)

Gilead Sciences (GILD) has reported Current Deferred Tax Assets for 8 consecutive years, with $857.0 million the latest figure, recorded in Q4 2016.

• For the quarter ending Q4 2016, Current Deferred Tax Assets rose 3.5% year-over-year to $857.0 million; the trailing twelve-month figure through Dec 2016 stood at $857.0 million (up 3.5% YoY), and the FY2016 full-year result was $857.0 million, up 3.5% from the prior year.
• Current Deferred Tax Assets climbed to $857.0 million in Q4 2016 per GILD's latest filing, from $762.0 million in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $894.0 million in Q3 2015 and bottomed at $193.9 million in Q1 2012.
• Historically, Current Deferred Tax Assets has averaged $501.1 million across 5 years, with a median of $385.6 million in 2014.
• The sharpest annual moves came in 2012 and 2015: Current Deferred Tax Assets tumbled 30.2% in 2012, then surged 132.46% in 2015.
• Over 5 years, Current Deferred Tax Assets stood at $262.6 million in 2012, then climbed by 26.03% to $331.0 million in 2013, then soared by 53.47% to $508.0 million in 2014, then surged by 62.99% to $828.0 million in 2015, then rose by 3.5% to $857.0 million in 2016.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $857.0 million, $762.0 million, and $835.0 million for Q4 2016, Q3 2016, and Q2 2016 respectively.